Drug retailers feel the heat as Amazon launches online pharmacy
Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.
avatar
Staff or Guest writer for The Dog of Wall Street.
2020-11-17 12:53

Amazon.com Inc. has launched an online pharmacy for selling prescription medicines across the U.S. Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.

Drug retailers feel the heat as Amazon launches online pharmacy

The new store, named Amazon Pharmacy, will allow customers to compare prices of the medicines on the app. They can choose between their copayment and a non-insurance option while checking out. Amazon will offer heavy discount to its prime members on the store.

The Seattle, Washington-based company has disrupted many industries along its tremendous growth journey. Amazon, which initially started its operations as an online bookseller, has been giving tough competition to companies in the retail and computing industries, and now the leading players in the pharmaceutical market will also face the heat after the latest announcement. The company has also faced criticism from labor groups and regulators in the past over its size and power.

The e-commerce giant’s new venture will now directly compete with Walgreens Boots, CVS Health, Walmart, Rite Aid, Kroger, and others. Online purchase of medicines has been relatively low as compared to physical store purchases. However, the pandemic may drive the online sales of drugs.

In case of Amazon, its prime members maybe more inclined to order drugs online through its newly opened store, as the company is offering up to 80 percent discount on generic and up to 40 percent discount on brand drugs when prime members decide to pay without insurance.

Amazon (NASDAQ: AMZN) shares slightly moved up in the mid-day trading Tuesday. If we look at the performance of the stock in the recent months, the stock has jumped more than 70 percent on year-to-date basis, about +31 percent over the past 6 months, and stayed nearly flat during the past 3 months.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2020-11-17 12:53

avatar
About the Author
Staff or Guest writer for The Dog of Wall Street.


buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

2 Earnings To Pay Attention to Next Week
Since big tech is the theme, you probably know what I have my eyes on for next week.
By Mike Sakuraba | 4 months ago

2 Stocks to Watch Below $10
Here are two stocks that are currently less trading in the single digits that I believe have some relative upside from their current prices.
By Mike Sakuraba | 4 months ago

2 Stocks to Load Up On During This Correction
Another volatile week for markets and investors are starting to feel a little uncomfortable.
By Mike Sakuraba | 4 months ago

Should We Buy This Dip in NVDA and Semis?
On Friday, the semiconductor industry finally saw its bubble burst. Many have been calling for a reset in prices on semiconductor stocks and we definitely got one.
By Mike Sakuraba | 4 months ago

Looking Ahead to Tesla's Earnings: What Can We Expect?
Is there any stock that has been more talked about than Tesla (NASDAQ: TSLA) as of late? It’s a company that is always in the spotlight but the stock is under some heavy scrutiny this year and deservedly so.
By Mike Sakuraba | 4 months ago

2 Earnings to Watch for Next Week
This article is merely meant to talk about two companies that I’ll have my eyes on for earnings.
By Mike Sakuraba | 4 months ago

2 Stocks That Could Explode in Q2
Here are two stocks that I think could explode in the second quarter.
By Mike Sakuraba | 4 months ago

2 Trillion Dollar Companies in the Making
One thing for certain about these two companies is that I see the potential in how they can grow.
By Mike Sakuraba | 4 months ago